PUBLISHER: Grand View Research | PRODUCT CODE: 1301144
PUBLISHER: Grand View Research | PRODUCT CODE: 1301144
The global pelvic floor electric stimulator market size is anticipated to reach USD 539.38 million by 2030, registering a CAGR of 11.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of Urinary Incontinence (UI), rising investment in research and development by key players, and the growing number of awareness initiatives are anticipated to boost the market growth. Increasing cases of chronic diseases and UI are primary factors that are expected to drive market growth. According to the NHS, around 61% of the male population is suffering from lower urinary tract infections and around 34% of women are living with some type of UI. This disorder costs around USD 301.40 million per year to the NHS. Thereby, contributing to market growth.
Moreover, the geriatric population is at a higher risk for developing various neurological conditions, such as stroke, prostate cancer, and Alzheimer's, which may affect the lower urinary tract. This factor is anticipated to be one of the high growth rendering drivers of this market. As per the WHO, the global population of people aged 65 years and above is expected to rise from 7.00% in 2000 to 16.00% in 2050. This is expected to drive the market at a global level.Furthermore, the launch of technologically advanced products with comparatively lower prices is expected to drive market growth. For instance, in February 2020, Atlantic Therapeutics received U.S. FDA, clearance for the over-the-counter device INNOVO-a wearable and non-invasive pelvic floor muscle stimulator for treating stress urinary incontinence.